These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. "Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer". Markman M Gynecol Oncol; 2010 May; 117(2):390; author reply 391. PubMed ID: 20149423 [No Abstract] [Full Text] [Related]
9. Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma. Trimble EL; Christian MC Gynecol Oncol; 2006 Jan; 100(1):3-4. PubMed ID: 16368439 [No Abstract] [Full Text] [Related]
10. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option. Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421 [TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal chemotherapy in ovarian carcinoma with the combination of carboplatin and 5-fluorouracil. Polyzos A; Giannikos L; Agrafiotis A; Kazaz M; Zonas C; Sfikakis P J Chemother; 1989 Jul; 1(4 Suppl):1220-1. PubMed ID: 16312842 [No Abstract] [Full Text] [Related]
14. [Theoretical and experimental bases for intraperitoneal chemotherapy in abdominal neoplastic processes]. Marinov L Khirurgiia (Sofiia); 1986; 39(4):11-7. PubMed ID: 3784379 [No Abstract] [Full Text] [Related]
15. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Petru E; Benedicic Ch; Huell A Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354 [No Abstract] [Full Text] [Related]
16. Intraperitoneal therapy for ovarian cancer: why has it not become standard? Rowan K J Natl Cancer Inst; 2009 Jun; 101(11):775-7. PubMed ID: 19470952 [No Abstract] [Full Text] [Related]
17. [Bowel injury caused by a catheter for Intraperitoneal chemotherapy--a case report]. Yamauchi I; Higashi M; Yoshioka M; Koyama N; Hashimoto M; Takahashi K; Nakamura Y Gan To Kagaku Ryoho; 1996 Oct; 23(12):1713-6. PubMed ID: 8886051 [TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166 [No Abstract] [Full Text] [Related]
19. Challenges of IP chemotherapy for ovarian cancer. Anselmo-Murphy AM Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604 [No Abstract] [Full Text] [Related]
20. Chemotherapy delivered into abdomen may extend ovarian cancer survival. Mayo Clin Womens Healthsource; 2006 Jun; 10(6):3. PubMed ID: 16675917 [No Abstract] [Full Text] [Related] [Next] [New Search]